The Real-World Effectiveness, Persistence, Adherence, and Safety of Janus Kinase Inhibitor Baricitinib in Rheumatoid Arthritis: A Long-Term Study
Article in Journal of Clinical Medicine (April 2024)
The most recent citing publications are shown below. View all 28 publications that cite this research output on Dimensions.
Real-Life Comparison of Four JAK Inhibitors in Rheumatoid Arthritis (ELECTRA-i Study)
Article in Journal of Clinical Medicine (March 2024)
Analysis of survival rate and persistence predictors of baricitinib in real-world data from a large cohort of rheumatoid arthritis patients
Article in Current Research in Pharmacology and Drug Discovery (February 2024)